Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
Virginia Bioscience Commercialization Luncheon - November 2015
Tell a Friend About This EventTell a Friend
 

Monthly statewide bioscience luncheon held in Richmond, VA.

11/12/2015
When: Thursday, Nov 12
11:30 AM - 1:30 PM
Where: Virginia Biotechnology Research Park
800 E. Leigh St.
Richmond, Virginia  23227
United States
Contact: Liz Kelly
804-643-6360


Online registration is closed.
« Go to Upcoming Event List  

Family Funds investing in innovative biomedical companies and nonprofits

 

The family fund has emerged as an important new source of capital to propel bioscience innovation and commercialization. Using wealth accumulated for making big impact, family funds invest in small and emerging companies, and make venture philanthropy investment type donations to nonprofits doing important focused work.

 

Speakers: 

James Benedict is a Managing Director of Cavendish Global and a partner with Kidd & Company, a leading U.S. private equity firm. He has also been a venture capitalist, an entrepreneur and a consultant to the World Bank and Japanese Ministry of Finance. James has a passion for bringing people together in novel and synergistic ways to drive value for enterprises that advance the state of affairs in education and for women & girls. He is a founding advisory board member of the Women’s Investment Network (WIN), a philanthropic and advocacy initiative aimed at catalyzing the next wave of social investors setting out to improve the health and rights of girls and women worldwide. James serves on the boards of Young Audiences Charter School in New Orleans, Acupera, Levo League, MOGUL, and Mission: Restore & Cerego. James is also an advisor to Dr. Bob Bollinger of the Johns Hopkins Center for Continuing Global Health Education. James has a Ph.D. in International Economics from Columbia University, a B.A. from Baylor University, and a Certificate on Monetary and Fiscal Policy from the Japanese Ministry of Finance.
 
Peter Harris is a Vice President & Managing Director at Axel Johnson, Inc. where he is involved with cultivating and evaluating new investment opportunities and providing strategic and operational support to existing portfolio companies. His areas of specific focus include industrial automation and advanced manufacturing, medical devices, life science and healthcare services, and in vitro diagnostics and analytical instrumentation. Prior to joining Axel Johnson, he was the CEO of Cadence, Inc. - a high technology medical device manufacturing and engineering firm enabling medical companies to bring better devices to market faster. Cadence has grown from an $8 million, 85% industrial products company to a $55 million 80% medical device and diagnostic products company. Peter has held the Cadence Chairman position since 2012. A persuasive public speaker, he regularly participates in community and industry events as a content provider. He also teaches at the University of Virginia’s Darden School of Business in the areas of leadership and change management. Undergraduate focus in mathematics and Mandarin. MBA from UVA. Dangerously rusty in Mandarin, but can still do rudimentary arithmetic as long as a calculator is handy.


Sponsors:


  

 

      


more Events

9/29/2016
MDMA 2016 Medical Technology Executive Forum

9/29/2016
Women Building Bio: The XX Factor

Premium Members

Membership Software Powered by YourMembership.com®  ::  Legal